IKT logo

Inhibikase Therapeutics, Inc.

IKT
Healthcare|Biotechnology|US
$1.50
+0.06 (+4.17%)
DCF Value
$1.41
Tangible Book / Share
$0.88
Cash / Share
$0.91

Ownership Breakdown

122.4%
Float
139.5M
Shares Outstanding
170.7M
Float Shares

Major Holders (30)

Combined: 242.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
RA Capital Management, L.P.IA, PN9.90%14,653,994Jul 31, 202613D/G
RA Capital Healthcare Fund, L.P.Partnership9.90%14,653,994Jul 31, 202613D/G
Peter KolchinskyHC, IN9.90%14,653,994Jul 31, 202613D/G
Rajeev ShahHC, IN9.90%14,653,994Jul 31, 202613D/G
ADAR1 Capital Management, LLCIA, OO9.90%13,860,028May 15, 202613D/G
Michael KramarzHC, IN9.90%14,054,940May 15, 202613D/G
Robert Egen AtkinsonHC, IN9.90%14,054,940May 15, 202613D/G
Commodore Capital Master LPPartnership9.90%14,054,940May 15, 202613D/G
Commodore Capital LPIA, PN9.90%14,054,940May 15, 202613D/G
Daniel SchneebergerHC, IN9.90%13,860,028May 15, 202613D/G
Fairmount Healthcare Fund II L.P.Partnership9.90%12,461,101Feb 17, 202613D/G
Fairmount Funds Management LLCInvestment adviser9.90%12,461,101Feb 17, 202613D/G
Tomas KiselakHC, IN9.90%12,461,101Feb 17, 202613D/G
Peter HarwinHC, IN9.90%12,461,101Feb 17, 202613D/G
Sands Capital Life Sciences Pulse Fund II, L.P.Partnership9.30%13,018,965Aug 13, 202613D/G
Sands Frank M.HC, IN9.30%13,018,965Aug 13, 202613D/G
Sands Capital Alternatives, LLCOther9.30%13,018,965Aug 13, 202613D/G
ADAR1 Capital Management GP, LLCOther8.50%11,832,998May 15, 202613D/G
Perceptive Life Sciences Master Fund, Ltd.Corporation6.90%10,320,875Aug 14, 202613D/G
Perceptive Advisors LLCInvestment adviser6.90%10,320,875Aug 14, 202613D/G
Joseph EdelmanIndividual6.90%10,320,875Aug 14, 202613D/G
Trails Edge Capital Partners, LPIA, PN6.10%8,057,345May 15, 202613D/G
Trails Edge Biotechnology Master Fund, LPPartnership6.10%8,057,345May 15, 202613D/G
Ortav YehudaiIndividual6.10%8,057,345May 15, 202613D/G
BlackRock, Inc.Holding company5.90%7,768,004Jul 28, 202613D/G
Armistice Capital, LLCIA, OO4.99%3,529,006Feb 14, 202513D/G
Steven BoydHC, IN4.99%3,529,006Feb 14, 202513D/G
Nantahala Capital Management, LLCInvestment adviser4.30%5,810,487Aug 14, 202613D/G
Daniel MackHolding company4.30%5,810,487Aug 14, 202613D/G
Wilmot B. HarkeyHolding company4.30%5,810,487Aug 14, 202613D/G

Insider Trades (100)

Last 4 quarters: 26,160,996 acquired · 18,664,524 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Wasserman Scott M.directorOct 19, 2026AWARD310,000$1.65$509.9KForm 4
Wasserman Scott M.Oct 19, 2026OTHER0——Form 4
RA CAPITAL MANAGEMENT, L.P.10 percent ownerJul 29, 2026J18,030,000$0.00$18.0KForm 4
RA CAPITAL MANAGEMENT, L.P.10 percent ownerJul 29, 2026DISPOSED18,030,000$0.00$18.0KForm 4
BERMAN DENNIS NdirectorJul 30, 2026OPTION EX.21,854$1.26$27.5KForm 4
BERMAN DENNIS NdirectorJul 30, 2026OPTION EX.21,854$1.26$27.5KForm 4
RA CAPITAL MANAGEMENT, L.P.10 percent ownerJul 10, 2026OTHER0——Form 4
BERMAN DENNIS NdirectorJun 26, 2026AWARD155,000$1.91$296.1KForm 4
Canner DaviddirectorJun 26, 2026AWARD155,000$1.91$296.1KForm 4
Kush ArvinddirectorJun 26, 2026AWARD155,000$1.91$296.1KForm 4
Bellini RobertodirectorJun 26, 2026AWARD155,000$1.91$296.1KForm 4
Aurentz VincentdirectorJun 26, 2026AWARD155,000$1.91$296.1KForm 4
Munshi AmitdirectorJun 26, 2026AWARD155,000$1.91$296.1KForm 4
Aurentz VincentdirectorFeb 21, 2026DISPOSED255,299——Form 4
Cabell ChristopherPresident & Head of R&DFeb 21, 2026DISPOSED338,282——Form 4
Munshi AmitdirectorFeb 21, 2026DISPOSED19,089——Form 4
Iwicki Mark Tdirector, officer: Chief Executive OfficerJan 5, 2026AWARD4,982,706$2.01$10.0MForm 4
Cabell ChristopherPresident & Head of R&DJan 5, 2026AWARD900,117$2.01$1.8MForm 4
McIntyre DavidChief Financial OfficerJan 5, 2026AWARD986,319$2.01$2.0MForm 4
Sands Capital Life Sciences Pulse Fund II, L.P.10 percent ownerNov 21, 2025BUY2,068,965$1.45$3.0MForm 4
Cabell ChristopherPresident & Head of R&DFeb 21, 2025OTHER0——Form 4
Aurentz VincentdirectorFeb 21, 2025OTHER0——Form 4
Munshi AmitdirectorFeb 21, 2025AWARD57,265——Form 4
Sands Capital Life Sciences Pulse Fund II, L.P.10 percent ownerJun 6, 2025OTHER0——Form 4
Cabell ChristopherPresident & Head of R&DFeb 21, 2025AWARD1,100,705$2.97$3.3MForm 4
Iwicki Mark Tdirector, officer: Chief Executive OfficerFeb 21, 2025AWARD602,346$2.97$1.8MForm 4
Aurentz VincentdirectorFeb 21, 2025AWARD134,427$2.97$399.2KForm 4
Aurentz VincentdirectorJun 30, 2025AWARD108,176$1.95$210.9KForm 4
Canner DaviddirectorJun 30, 2025AWARD108,176$1.95$210.9KForm 4
Munshi AmitdirectorJun 30, 2025AWARD108,176$1.95$210.9KForm 4
Kush ArvinddirectorJun 30, 2025AWARD108,176$1.95$210.9KForm 4
BERMAN DENNIS NdirectorJun 30, 2025AWARD108,176$1.95$210.9KForm 4
Bellini RobertodirectorJun 30, 2025AWARD108,176$1.95$210.9KForm 4
McIntyre DavidChief Financial OfficerApr 14, 2025AWARD1,775,539$2.00$3.6MForm 4
McIntyre DavidChief Financial OfficerApr 14, 2025OTHER0——Form 4
Cabell ChristopherPresident & Head of R&DFeb 21, 2025AWARD1,100,705$2.23$2.5MForm 4
Aurentz VincentdirectorFeb 21, 2025AWARD134,427$2.23$299.8KForm 4
Iwicki Mark Tdirector, officer: Chief Executive OfficerFeb 21, 2025AWARD602,346$2.23$1.3MForm 4
Cabell ChristopherFeb 21, 2025OTHER0——Form 4
Aurentz VincentFeb 21, 2025OTHER0——Form 4
Iwicki Mark Tdirector, officer: Chief Executive OfficerFeb 14, 2025AWARD4,373,857$2.35$10.3MForm 4
Iwicki Mark Tdirector, officer: Chief Executive OfficerFeb 17, 2025AWARD1,794,291$2.35$4.2MForm 4
Iwicki Mark TFeb 14, 2025OTHER0——Form 4
Kush ArvinddirectorFeb 14, 2025AWARD116,585$2.35$274.0KForm 4
Kush ArvinddirectorFeb 14, 2025AWARD56,600$2.35$133.0KForm 4
Bellini RobertodirectorFeb 14, 2025AWARD116,585$2.35$274.0KForm 4
Bellini RobertodirectorFeb 14, 2025AWARD73,580$2.35$172.9KForm 4
Freeman Roy LesterdirectorFeb 14, 2025AWARD22,640$2.35$53.2KForm 4
Munshi AmitdirectorFeb 14, 2025AWARD116,585$2.35$274.0KForm 4
Munshi AmitdirectorFeb 14, 2025AWARD56,600$2.35$133.0KForm 4
Canner DaviddirectorFeb 14, 2025AWARD116,585$2.35$274.0KForm 4
Canner DaviddirectorFeb 14, 2025AWARD22,640$2.35$53.2KForm 4
BERMAN DENNIS NdirectorFeb 14, 2025AWARD39,620$2.35$93.1KForm 4
Lees-Rolfe GarthChief Financial OfficerJan 21, 2025AWARD90,000$1.26$113.4KForm 4
Lees-Rolfe GarthChief Financial OfficerJan 21, 2025AWARD5,834$1.26$7.4KForm 4
Lees-Rolfe GarthChief Financial OfficerJan 21, 2025DISPOSED90,000$2.16$194.4KForm 4
Lees-Rolfe GarthChief Financial OfficerJan 21, 2025DISPOSED5,834$3.79$22.1KForm 4
Freeman Roy LesterdirectorJan 21, 2025AWARD30,000$1.26$37.8KForm 4
Freeman Roy LesterdirectorJan 21, 2025AWARD21,854$1.26$27.5KForm 4
Freeman Roy LesterdirectorJan 21, 2025AWARD6,667$1.26$8.4KForm 4
Freeman Roy LesterdirectorJan 21, 2025AWARD3,780$1.26$4.8KForm 4
Freeman Roy LesterdirectorJan 21, 2025AWARD1,138$1.26$1.4KForm 4
Freeman Roy LesterdirectorJan 21, 2025DISPOSED6,667$3.61$24.1KForm 4
Freeman Roy LesterdirectorJan 21, 2025DISPOSED21,854$33.43$730.6KForm 4
Freeman Roy LesterdirectorJan 21, 2025DISPOSED1,138$60.00$68.3KForm 4
Freeman Roy LesterdirectorJan 21, 2025DISPOSED3,780$17.52$66.2KForm 4
Freeman Roy LesterdirectorJan 21, 2025DISPOSED6,667$4.86$32.4KForm 4
Freeman Roy LesterdirectorJan 21, 2025DISPOSED30,000$1.54$46.2KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025AWARD45,000$1.26$56.7KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025AWARD35,000$1.26$44.1KForm 4
BERMAN DENNIS NdirectorJan 21, 2025AWARD30,000$1.26$37.8KForm 4
BERMAN DENNIS NdirectorJan 21, 2025AWARD21,854$1.26$27.5KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025AWARD20,834$1.26$26.3KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025AWARD16,667$1.26$21.0KForm 4
BERMAN DENNIS NdirectorJan 21, 2025AWARD6,667$1.26$8.4KForm 4
BERMAN DENNIS NdirectorJan 21, 2025AWARD3,780$1.26$4.8KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025AWARD3,643$1.26$4.6KForm 4
BERMAN DENNIS NdirectorJan 21, 2025AWARD1,138$1.26$1.4KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025DISPOSED3,643$33.43$121.8KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025DISPOSED3,643$13.86$50.5KForm 4
BERMAN DENNIS NdirectorJan 21, 2025DISPOSED21,854$33.43$730.6KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025DISPOSED35,000$4.44$155.4KForm 4
BERMAN DENNIS NdirectorJan 21, 2025DISPOSED6,667$4.86$32.4KForm 4
BERMAN DENNIS NdirectorJan 21, 2025DISPOSED6,667$3.61$24.1KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025DISPOSED45,000$2.16$97.2KForm 4
BERMAN DENNIS NdirectorJan 21, 2025DISPOSED3,780$17.52$66.2KForm 4
BERMAN DENNIS NdirectorJan 21, 2025DISPOSED30,000$1.54$46.2KForm 4
BERMAN DENNIS NdirectorJan 21, 2025DISPOSED1,138$60.00$68.3KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025DISPOSED20,834$6.42$133.8KForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025DISPOSED16,667$60.00$1.0MForm 4
Werner Milton H.director, officer: President and CEOJan 21, 2025DISPOSED3,643$28.76$104.8KForm 4
Werner Milton H.director, officer: President and CEOJan 3, 2025AWARD5,315,056$1.26$6.7MForm 4
Werner Milton H.director, officer: President and CEOJan 3, 2025AWARD4,059,744$1.58$6.4MForm 4
Werner Milton H.director, officer: President and CEOJan 3, 2025AWARD2,207,671$1.45$3.2MForm 4
Lees-Rolfe GarthChief Financial OfficerJan 3, 2025AWARD470,861$1.26$593.3KForm 4
Lees-Rolfe GarthChief Financial OfficerJan 3, 2025AWARD432,853$1.58$683.9KForm 4
Lees-Rolfe GarthChief Financial OfficerJan 3, 2025AWARD235,383$1.45$341.3KForm 4
Freeman Roy LesterdirectorJan 3, 2025AWARD344,452$1.26$434.0KForm 4
Freeman Roy LesterdirectorJan 3, 2025AWARD316,647$1.58$500.3KForm 4
Freeman Roy LesterdirectorJan 3, 2025AWARD172,191$1.45$249.7KForm 4